Abstract
The diarylquinoline F1FO-ATP synthase inhibitor bedaquiline (BDQ) displays protonophore activity. Thus, uncoupling electron transport from ATP synthesis appears to be a second mechanism of action of this antimycobacterial drug. Here, we show that the new BDQ analogue TBAJ-876 did not retain the parental drug's protonophore activity. Comparative time-kill analyses revealed that both compounds exert the same bactericidal activity. These results suggest that the uncoupler activity is not required for the bactericidal activity of diarylquinolines.
| Original language | English |
|---|---|
| Article number | e01540 |
| Journal | Antimicrobial Agents and Chemotherapy |
| Volume | 64 |
| Issue number | 2 |
| DOIs | |
| State | Published - 27 Jan 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Bedaquiline
- Protonophore
- TBAJ-876
- Tuberculosis
- Uncoupler
Fingerprint
Dive into the research topics of 'TBAJ-876 displays bedaquiline-like mycobactericidal potency without retaining the parental drug's uncoupler activity'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver